Cargando…

Sequential allogeneic transplantation and ruxolitinib maintenance for a synchronous PCM1‐JAK2 positive myeloid sarcoma and acute B‐lymphoblastic leukemia

The translocation t(8;9)(p22;p24) results in the production of a chimeric PCM1‐JAK2 fusion protein leading to the constitutive activation of the Janus Kinase 2 that renders this disease potentially sensitive to ruxolitinib. Here, we report an interesting case of PCM1‐JAK2 myeloproliferative neoplasm...

Descripción completa

Detalles Bibliográficos
Autores principales: Rizzuto, Giuliana, Leoncin, Matteo, Imbergamo, Silvia, Taurino, Daniela, Mico, Maria Caterina, Tosi, Manuela, Michelato, Anna, Buklijas, Ksenija, Spinelli, Orietta, Lussana, Federico, Lessi, Federica, Pizzi, Marco, Bonaldi, Laura, Binotto, Gianni, Rambaldi, Alessandro, Gurrieri, Carmela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741870/
https://www.ncbi.nlm.nih.gov/pubmed/35028141
http://dx.doi.org/10.1002/ccr3.5212
_version_ 1784629585260838912
author Rizzuto, Giuliana
Leoncin, Matteo
Imbergamo, Silvia
Taurino, Daniela
Mico, Maria Caterina
Tosi, Manuela
Michelato, Anna
Buklijas, Ksenija
Spinelli, Orietta
Lussana, Federico
Lessi, Federica
Pizzi, Marco
Bonaldi, Laura
Binotto, Gianni
Rambaldi, Alessandro
Gurrieri, Carmela
author_facet Rizzuto, Giuliana
Leoncin, Matteo
Imbergamo, Silvia
Taurino, Daniela
Mico, Maria Caterina
Tosi, Manuela
Michelato, Anna
Buklijas, Ksenija
Spinelli, Orietta
Lussana, Federico
Lessi, Federica
Pizzi, Marco
Bonaldi, Laura
Binotto, Gianni
Rambaldi, Alessandro
Gurrieri, Carmela
author_sort Rizzuto, Giuliana
collection PubMed
description The translocation t(8;9)(p22;p24) results in the production of a chimeric PCM1‐JAK2 fusion protein leading to the constitutive activation of the Janus Kinase 2 that renders this disease potentially sensitive to ruxolitinib. Here, we report an interesting case of PCM1‐JAK2 myeloproliferative neoplasm evolving in myeloid sarcoma and B precursor ALL.
format Online
Article
Text
id pubmed-8741870
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-87418702022-01-12 Sequential allogeneic transplantation and ruxolitinib maintenance for a synchronous PCM1‐JAK2 positive myeloid sarcoma and acute B‐lymphoblastic leukemia Rizzuto, Giuliana Leoncin, Matteo Imbergamo, Silvia Taurino, Daniela Mico, Maria Caterina Tosi, Manuela Michelato, Anna Buklijas, Ksenija Spinelli, Orietta Lussana, Federico Lessi, Federica Pizzi, Marco Bonaldi, Laura Binotto, Gianni Rambaldi, Alessandro Gurrieri, Carmela Clin Case Rep Case Report The translocation t(8;9)(p22;p24) results in the production of a chimeric PCM1‐JAK2 fusion protein leading to the constitutive activation of the Janus Kinase 2 that renders this disease potentially sensitive to ruxolitinib. Here, we report an interesting case of PCM1‐JAK2 myeloproliferative neoplasm evolving in myeloid sarcoma and B precursor ALL. John Wiley and Sons Inc. 2022-01-07 /pmc/articles/PMC8741870/ /pubmed/35028141 http://dx.doi.org/10.1002/ccr3.5212 Text en © 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Report
Rizzuto, Giuliana
Leoncin, Matteo
Imbergamo, Silvia
Taurino, Daniela
Mico, Maria Caterina
Tosi, Manuela
Michelato, Anna
Buklijas, Ksenija
Spinelli, Orietta
Lussana, Federico
Lessi, Federica
Pizzi, Marco
Bonaldi, Laura
Binotto, Gianni
Rambaldi, Alessandro
Gurrieri, Carmela
Sequential allogeneic transplantation and ruxolitinib maintenance for a synchronous PCM1‐JAK2 positive myeloid sarcoma and acute B‐lymphoblastic leukemia
title Sequential allogeneic transplantation and ruxolitinib maintenance for a synchronous PCM1‐JAK2 positive myeloid sarcoma and acute B‐lymphoblastic leukemia
title_full Sequential allogeneic transplantation and ruxolitinib maintenance for a synchronous PCM1‐JAK2 positive myeloid sarcoma and acute B‐lymphoblastic leukemia
title_fullStr Sequential allogeneic transplantation and ruxolitinib maintenance for a synchronous PCM1‐JAK2 positive myeloid sarcoma and acute B‐lymphoblastic leukemia
title_full_unstemmed Sequential allogeneic transplantation and ruxolitinib maintenance for a synchronous PCM1‐JAK2 positive myeloid sarcoma and acute B‐lymphoblastic leukemia
title_short Sequential allogeneic transplantation and ruxolitinib maintenance for a synchronous PCM1‐JAK2 positive myeloid sarcoma and acute B‐lymphoblastic leukemia
title_sort sequential allogeneic transplantation and ruxolitinib maintenance for a synchronous pcm1‐jak2 positive myeloid sarcoma and acute b‐lymphoblastic leukemia
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741870/
https://www.ncbi.nlm.nih.gov/pubmed/35028141
http://dx.doi.org/10.1002/ccr3.5212
work_keys_str_mv AT rizzutogiuliana sequentialallogeneictransplantationandruxolitinibmaintenanceforasynchronouspcm1jak2positivemyeloidsarcomaandacuteblymphoblasticleukemia
AT leoncinmatteo sequentialallogeneictransplantationandruxolitinibmaintenanceforasynchronouspcm1jak2positivemyeloidsarcomaandacuteblymphoblasticleukemia
AT imbergamosilvia sequentialallogeneictransplantationandruxolitinibmaintenanceforasynchronouspcm1jak2positivemyeloidsarcomaandacuteblymphoblasticleukemia
AT taurinodaniela sequentialallogeneictransplantationandruxolitinibmaintenanceforasynchronouspcm1jak2positivemyeloidsarcomaandacuteblymphoblasticleukemia
AT micomariacaterina sequentialallogeneictransplantationandruxolitinibmaintenanceforasynchronouspcm1jak2positivemyeloidsarcomaandacuteblymphoblasticleukemia
AT tosimanuela sequentialallogeneictransplantationandruxolitinibmaintenanceforasynchronouspcm1jak2positivemyeloidsarcomaandacuteblymphoblasticleukemia
AT michelatoanna sequentialallogeneictransplantationandruxolitinibmaintenanceforasynchronouspcm1jak2positivemyeloidsarcomaandacuteblymphoblasticleukemia
AT buklijasksenija sequentialallogeneictransplantationandruxolitinibmaintenanceforasynchronouspcm1jak2positivemyeloidsarcomaandacuteblymphoblasticleukemia
AT spinelliorietta sequentialallogeneictransplantationandruxolitinibmaintenanceforasynchronouspcm1jak2positivemyeloidsarcomaandacuteblymphoblasticleukemia
AT lussanafederico sequentialallogeneictransplantationandruxolitinibmaintenanceforasynchronouspcm1jak2positivemyeloidsarcomaandacuteblymphoblasticleukemia
AT lessifederica sequentialallogeneictransplantationandruxolitinibmaintenanceforasynchronouspcm1jak2positivemyeloidsarcomaandacuteblymphoblasticleukemia
AT pizzimarco sequentialallogeneictransplantationandruxolitinibmaintenanceforasynchronouspcm1jak2positivemyeloidsarcomaandacuteblymphoblasticleukemia
AT bonaldilaura sequentialallogeneictransplantationandruxolitinibmaintenanceforasynchronouspcm1jak2positivemyeloidsarcomaandacuteblymphoblasticleukemia
AT binottogianni sequentialallogeneictransplantationandruxolitinibmaintenanceforasynchronouspcm1jak2positivemyeloidsarcomaandacuteblymphoblasticleukemia
AT rambaldialessandro sequentialallogeneictransplantationandruxolitinibmaintenanceforasynchronouspcm1jak2positivemyeloidsarcomaandacuteblymphoblasticleukemia
AT gurriericarmela sequentialallogeneictransplantationandruxolitinibmaintenanceforasynchronouspcm1jak2positivemyeloidsarcomaandacuteblymphoblasticleukemia